drug · small molecule
delgocitinib
Marketedupdated 3mo agoby Leo Pharma AS🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 4 investigational indications.
targets
Janus Kinase (JAK)
all catalysts(0)
nothing on the calendar yet
Trials studying delgocitinib
- phase3A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
- phase2A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- phase2Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris
- phase3Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema
- phase3A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema
- phase3A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema
- phase3Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials
- phase3Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 23, 2030
~3.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Sep 19, 2031compositionUS 8609647
FDA exclusivities (1)
- Jul 23, 2030NCENew Chemical Entity (5y)3.9y
News(1)
- LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drugThis is the third recent acquisition conducted by Denmark’s LEO Pharma in medical dermatology, a portfolio that marked 12% growth in the first half of the year.biospace · 2d ago
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that